Simplicity Wealth’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,536
Closed -$24.7K 648
2025
Q1
$24.7K Buy
+2,536
New +$24.9K ﹤0.01% 553

Other funds holding RAPT

Simplicity Wealth's RAPT Position: Q2 2025 in Review

Simplicity Wealth sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 2,536 shares — an estimated $24.7K sold.

Simplicity Wealth first reported a position in RAPT in Q1 2025 and held it in 1 quarter. The position peaked at $24.7K in Q1 2025. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Simplicity Wealth reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplicity Wealth sold 2,536 RAPT Therapeutics shares in Q2 2025, an estimated $24.7K.
  • Simplicity Wealth first reported a position in RAPT Therapeutics in Q1 2025 and held it in 1 quarter.
  • Simplicity Wealth's RAPT Therapeutics position peaked at $24.7K in Q1 2025.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Simplicity Wealth's 13F filing for Q2 2025, filed 22 Jul 2025.